BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19825990)

  • 21. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X; Zhang J; Wang L; Wei H; Tian Z
    BMC Cancer; 2007 Aug; 7():149. PubMed ID: 17683579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression.
    Zhao A; Zeng Q; Xie X; Zhou J; Yue W; Li Y; Pei X
    J Genet Genomics; 2012 Jan; 39(1):29-35. PubMed ID: 22293115
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abrogation of c-Raf expression induces apoptosis in tumor cells.
    Lau QC; Brüsselbach S; Müller R
    Oncogene; 1998 Apr; 16(14):1899-902. PubMed ID: 9583688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA miR-125b induces senescence in human melanoma cells.
    Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
    Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells.
    Bandres E; Bitarte N; Arias F; Agorreta J; Fortes P; Agirre X; Zarate R; Diaz-Gonzalez JA; Ramirez N; Sola JJ; Jimenez P; Rodriguez J; Garcia-Foncillas J
    Clin Cancer Res; 2009 Apr; 15(7):2281-90. PubMed ID: 19318487
    [TBL] [Abstract][Full Text] [Related]  

  • 26. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma.
    Kefas B; Godlewski J; Comeau L; Li Y; Abounader R; Hawkinson M; Lee J; Fine H; Chiocca EA; Lawler S; Purow B
    Cancer Res; 2008 May; 68(10):3566-72. PubMed ID: 18483236
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of microRNAs in drug-resistant ovarian cancer cells.
    Sorrentino A; Liu CG; Addario A; Peschle C; Scambia G; Ferlini C
    Gynecol Oncol; 2008 Dec; 111(3):478-86. PubMed ID: 18823650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein kinase C beta enhances growth and expression of cyclin D1 in human breast cancer cells.
    Li H; Weinstein IB
    Cancer Res; 2006 Dec; 66(23):11399-408. PubMed ID: 17145886
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Down-regulation and growth inhibitory role of C/EBPalpha in breast cancer.
    Gery S; Tanosaki S; Bose S; Bose N; Vadgama J; Koeffler HP
    Clin Cancer Res; 2005 May; 11(9):3184-90. PubMed ID: 15867211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of microRNA-125b expression in MCF7 breast cancer cells by ATR-FTIR spectroscopy.
    Ozek NS; Tuna S; Erson-Bensan AE; Severcan F
    Analyst; 2010 Dec; 135(12):3094-102. PubMed ID: 20978686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA miR-125b is a prognostic marker in human colorectal cancer.
    Nishida N; Yokobori T; Mimori K; Sudo T; Tanaka F; Shibata K; Ishii H; Doki Y; Kuwano H; Mori M
    Int J Oncol; 2011 May; 38(5):1437-43. PubMed ID: 21399871
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of microRNA-145 for therapeutic application in breast cancer.
    Kim SJ; Oh JS; Shin JY; Lee KD; Sung KW; Nam SJ; Chun KH
    J Control Release; 2011 Nov; 155(3):427-34. PubMed ID: 21723890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1.
    Han Y; Liu Y; Zhang H; Wang T; Diao R; Jiang Z; Gui Y; Cai Z
    FEBS Lett; 2013 Nov; 587(23):3875-82. PubMed ID: 24396870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [siRNA-mediated inhibition of ErbB2 expression and its effect on breast cancer cell growth].
    Jiang K; Yang ZH; Wang ZY; Xu XJ; Cheng L; Zhang H; Han YJ; Ye QN
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Mar; 27(3):257-9. PubMed ID: 21419042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-125b down-regulation mediates endometrial cancer invasion by targeting ERBB2.
    Shang C; Lu YM; Meng LR
    Med Sci Monit; 2012 Apr; 18(4):BR149-55. PubMed ID: 22460089
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antisense raf oligodeoxyribonucleotide is a radiosensitizer in vivo.
    Gokhale PC; McRae D; Monia BP; Bagg A; Rahman A; Dritschilo A; Kasid U
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):191-201. PubMed ID: 10355825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miR-125b targets erythropoietin and its receptor and their expression correlates with metastatic potential and ERBB2/HER2 expression.
    Ferracin M; Bassi C; Pedriali M; Pagotto S; D'Abundo L; Zagatti B; Corrà F; Musa G; Callegari E; Lupini L; Volpato S; Querzoli P; Negrini M
    Mol Cancer; 2013 Oct; 12(1):130. PubMed ID: 24165569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Overexpression of miR-125b promotes apoptosis of macrophages].
    Yu G; Zhan X; Zhang Z; Li Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Jul; 32(7):958-62. PubMed ID: 27363278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo expression of single-stranded DNA in mammalian cells with DNA enzyme sequences targeted to C-raf.
    Chen Y; Ji YJ; Roxby R; Conrad C
    Antisense Nucleic Acid Drug Dev; 2000 Dec; 10(6):415-22. PubMed ID: 11198925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
    Miko E; Margitai Z; Czimmerer Z; Várkonyi I; Dezso B; Lányi A; Bacsó Z; Scholtz B
    FEBS Lett; 2011 Apr; 585(8):1191-6. PubMed ID: 21439283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.